Updates are available Correction dated 2022-08-16
Click to view Correction: https://doi.org/10.1038/s42255-022-00635-4
-
Authors
Puurunen, Marja K. https://orcid.org/0000-0003-3810-5687
Vockley, Jerry
Searle, Shawn L.
Sacharow, Stephanie J.
Phillips, John A. III
Denney, William S. https://orcid.org/0000-0002-5759-428X
Goodlett, Benjamin D.
Wagner, David A.
Blankstein, Larry
Castillo, Mary J.
Charbonneau, Mark R. https://orcid.org/0000-0003-4893-8244
Isabella, Vincent M.
Sethuraman, Vasu V.
Riese, Richard J.
Kurtz, Caroline B. https://orcid.org/0000-0001-7192-6116
Brennan, Aoife M.
-
Funding
Funding for this research was provided by:
Synlogic Inc.
- License Information
-
More Information
Article History
Received: 17 February 2021
Accepted: 23 June 2021
First Online: 22 July 2021
Change Date: 16 August 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s42255-022-00635-4
Competing interests
: J.V. reports research funding from Biomarin Pharmaceuticals, Homology Pharmaceuticals, Nestle, PTC Therapeutics, outside the submitted work. M.K.P., L.B., V.V.S., V.M.I., M.J.C., M.R.C., R.J.R., C.B.K. and A.M.B. are full-time employees and hold equity in Synlogic Inc. D.A.W. receives a salary from Metabolic Solutions. Metabolic Solutions was paid a fee to analyse samples for this publication. W.S.D. is a consultant for Synlogic Inc. The remaining authors declare no competing interests.
